Picture of Vericel logo

VCEL — Vericel News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Vericel Corp reports results for the quarter ended in March - Earnings Summary

* Vericel Corp  VCEL.OQ  reported a quarterly adjusted loss
of 15
cents​​ per share for the quarter ended in March. The mean
expectation of six analysts for the quarter was for a loss of 12
cents per share.
    * Revenue rose 6.6% to $35.85 million from a year ago; 
analysts
expected $34.31 million. 
    * Vericel Corp's reported EPS for the quarter was a loss
of 15
cents​.
    * The mean earnings estimate of analysts had fallen by
about 112.1% in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Vericel Corp shares had fallen by 17.9% this quarter and
lost 20.2% so far this year.
    * The company reported a quarterly loss of $7.09 million.
    * Wall Street's median 12-month price target for Vericel
Corp is
$49.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated May 4 at 02:14 p.m.  ​All
figures in US dollars unless otherwise stated

Recent news on Vericel

See all news